Changes in adipopnectin, leptin, and fat mass after clenbuterol treatment in horses

Medicine and Science in Sports and Exercise

Volumn 38, Issue 2, 2006, Pages 262-267

  Kearns, Charles F ^a,b   McKeever, Kenneth H ^a,c   Malinowski, Karyn ^a  

^a The State University of New Jersey   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c Department of Animal Sciences ^*  (United States)

Author keywords

Adipocytokines; Equine; Training

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; LEPTIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; B SCAN; BODY FAT; BODY FAT DISTRIBUTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOCRINE FUNCTION; EXERCISE; FEMALE; HORMONE BLOOD LEVEL; HORSE; IMMUNOREACTIVITY; METABOLIC REGULATION; NONHUMAN; RADIOIMMUNOASSAY; THICKNESS;

ADIPONECTIN; ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BODY COMPOSITION; CLENBUTEROL; HORSES; LEPTIN; PHYSICAL CONDITIONING, ANIMAL;

EID: 33144475944     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000185108.63028.04     Document Type: Article

References (36)

1. ARITA, Y., S. KIHARA, N. OUCHI, et al. Paradoxical decrease of an adipose-specificprotein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257:79-83, 1999.
2. BAKER, P. K., R. H. DALRYMPLE, D. L. INGLE, and C. A. RICKS. Use of a β-adrenergic agonist to alter muscle and fat deposition in lambs. J. Anim. Sci. 59:1256-1261, 1984.
3. CASTLE, A., B. B. YASPELKIS, C. KUO, and J. L. IVY. Attenuation of insulin resistance by chronic β2-adrenergic agonist treatment. Possible muscle specific contributions. Life Sci. 69:599-611, 2001.
4. CONSIDINE, R. V., M. K. SINHA, M. L. HEIMAN, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295, 1996.
5. CLAEYS, M. C., D. R. MULVANEY, F. D. MCCARTHY, M. T. GORE, D. N. MARPLE, and J. L. SARTIN. Skeletal muscle protein synthesis and growth hormone secretion in young lambs treated with clenbuterol. J. Anim. Sci. 67:2245-2254, 1989.
6. DALRYMPLE, R. H., P. K. BAKER, P. K. GENGHER, D. L. INGLE, J. M. PENSACK, and C. A. RICKS. A repartitioning agent to improve performance and carcass composition in broilers. Poult. Sci. 63:2376-2383, 1984.
7. FITZGERALD, B. P., and C. J. MCMANUS. Photoperiodic versus metabolic signals as determinants of seasonal anestrus in the mare. Biol. Reprod. 63:335-340, 2000.
8. FUNAHASHI, T., T. NAKAMURA, I. SHIMOMURA, et al. Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity. Intern. Med. 38:202-206, 1999.
9. HAVEL, P. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr. Opin. Lipidol. 13:51-59, 2002.
10. HULVER, M., and J. HOUMARD, Plasma leptin and exercise: recent findings. Sports Med. 33:473-482, 2003.
11. HULVER, M. W., D. ZHENG, C. J. TANNER, et al. Adiponectin is not altered with exercise training despite enhanced insulin action. Am. J. Physiol. Endocrinol. Metab. 283:E861-E865, 2002.
12. Kane, R. A., M. Fisher, D. Parrett, and L. M. Lawrence. Estimating fatness in horses. In: Proceedings of the 10th Equine Nutritional Physiology Symposium, Fort Collins, CO., 1987, pp. 127-131.
13. KEARNS, C. F., K. H. MCKEEVER, R. ROEGNER, S. M. BRADY, and K. MALINOWSKI. Adiponectin and leptin are related to fat mass in horses. The Veterinary Journal (in press).
14. KEARNS, C. F., K. H. MCKEEVER, H. JOHN-ALDER, W. F. BRECHUE, and T. ABE. Relationship between body composition, blood volume and maximal oxygen uptake. Equine Veterinary Journal Supplement 34:485-490, 2002b.
15. KEARNS, C. F., W. F. MCKEEVER, and T. ABE. Overview of horse body composition and muscle architecture: implications for performance. The Veterinary Journal 164:224-234, 2002c.
16. KEARNS, C. F., K. H. MCKEEVER, K. KUMAGAI, and T. ABE. Fat-free mass is related to one-mile race performance in elite standard bred horses. The Veterinary Journal 163:260-266, 2002.
17. KEARNS, C. F., and K. H. MCKEEVER. Clenbuterol disrupts central mechanisms of aerobic performance in the horse. Med. Sci. Sports Exerc. 34:1976-1985, 2002.
18. KEARNS, C. F., K. H. MCKEEVER, K. MALINOWSKI, M. B. STRUCK, and T. ABE. Chronic clenbuterol administration acts as a repartitioning agent in horses. J. Appl. Physiol. 91:2064-2070, 2001.
19. KRAEMER, R., H. CHU, and V. D. CASTRACANE. Leptin and exercise. Exp. Biol. Med. 227:701-708, 2002.
20. LI, H., M. MATHENY, and P. J. SCARPACE. Beta 3-adrenergic-mediated suppression of leptin gene expression in rats. Am. J. Physiol. 272:E1031-E1036, 1997.
21. MACLENNAN, P. A., and R. H. T. EDWARDS. Effects of clenbuterol and propanol on muscle mass. Biochem. J. 264:573-579, 1989.
22. MALTIN, C. A., M. I. DELDAY, S. M. HAY, F. G. SMITH, G. E. LOBLEY, and P. J. REEDS. The effect of the anabolic agent, clenbuterol, on overloaded rat skeletal muscle. Biosci. Rep. 7:143-149, 1987.
23. MATSUZAWA, Y., T. FUNAHASHI, and T. NAKAMURA. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N. Y. Acad. Sci. 892:146-154, 1999.
24. MCMANUS, C. J., and B. P. FITZGERALD. Effects of a single day of feed restriction on changes in serum leptin, gonadotropins, prolactin, and metabolites in aged and young mares. Domest. Anim. Endocrinol. 19:1-13, 2000.
25. MOORE, G. B., H. CHAPMAN, J. C. HOLDER, et al. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem. Biophys. Res. Commun. 286:735-741, 2001.
26. MILLER, G. D., R. FROST, and J. OLIVE. Relation of plasma leptin concentrations to sex, body fat, dietary intake, and peak oxygen uptake in young adult women and men. Nutrition 17:105-111, 2001.
27. NEMET, D., P. WANG, T. FUNAHASHI, et al. Adipocytokines, body composition, and fitness in children. Pediatr. Res. 53:148-152, 2003.
28. REEDS, P. J., S. M. HAY, P. M. DORWARD, and R. M. PALMER. The effect of β-agonists and antagonists on muscle growth and body composition of young rats (Rattus SP). Comp. Biochem. Physiol. 89C:337-341, 1988.
29. RICKS, C. A., R. H. DALRYMPLE, P. K. BAKER, and D. L. INGLE. Use of a β-agonist to alter fat and muscle deposition in steers. J. Anim. Sci. 59:1247-1255, 1984.
30. SLEEPER, M., C. F. KEARNS, and K. H. MCKEEVER. Chronic clenbuterol administration negatively alters cardiac function in the horse. Med. Sci. Sports Exerc. 34:643-650, 2002.
31. STROSBERG, A. D. Structure and function of the β3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37:421-445, 1997.
32. TAKAHASHI, M., T. FUNAHASHI, I. SHIMOMURA, K. MIYAOKA, and Y. MATSUZAWA. Plasma leptin levels and body fat distribution. Horm. Metab. Res. 28:751-752, 1996.
33. TORGAN, C. E., G. J. ETGEN, JR., J. T. BROZINICK, JR., R. E. WILCOX, and J. L. IVY. Interaction of aerobic exercise training and clenbuterol: effects on insulin-resistant muscle. J. Appl. Physiol. 75:1471-1476, 1993.
34. WESTERVELT, R. G., J. R. STOUFFER, H. F. HINTZ, and H. F. SCHRYVER. Estimating fatness in horses and ponies. J. Anim. Sci. 43:781-785, 1976.
35. YANG, W. S., W. J. LEE, T. FUNAHASHI, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab. 86:3815-3819, 2001.
36. ZHANG, Y., M. MATHENY, S. ZOLOTUKHIN, N. TUMER, and P. J. SCARPACE. Regulation of adiponectin and leptin expression in white and brown adipose tissues: influence of b3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim. Biophys. Acta 1584:115-122, 2002.